<DOC>
	<DOCNO>NCT01204411</DOCNO>
	<brief_summary>The purpose study determine whether artesunate-amodiaquine combination effective treating uncomplicated Plasmodium falciparum malaria child severe acute malnutrition . Infection Plasmodium falciparum malaria remain significant cause morbidity mortality malnourish child . Malnutrition known modulate effect incidence malaria infection , severity effectiveness treatment . However , little data exist antimalarial drug efficacy malnourish child . Artesunate-amodiaquine combination first line treatment use Médecins Sans Frontières programmes Niger . The assumption current efficacy artesunate-amodiaquine base non malnourished child . The aim study measure clinical parasitological efficacy severely malnourish child . The study consistent standard WHO protocol monitor antimalarial drug efficacy ( WHO : Methods surveillance antimalarial drug efficacy . Geneva ; 2009 ) , except one inclusion criterion . Severe acute malnutrition inclusion criterion , instead exclusion criterion . The study encompass pharmacokinetic part provide important information absorption drug .</brief_summary>
	<brief_title>Efficacy Artesunate-amodiaquine ( AS-AQ ) Children With Malaria Severe Acute Malnutrition , Madaoua , Niger 2010</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Severe Acute Malnutrition</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Amodiaquine , artesunate drug combination</mesh_term>
	<criteria>Age 6 59 month Weight ≥5kg P. falciparum monoinfection confirm thick blood film Parasitic density 1,000 200,000 asexual forms/uL blood Measured axillary temperature ≥37.5°C history fever previous 24 hour Severe malnutrition ( defined weight/height ratio le 3 zscores ) High probability compliance followup visit ( home within two hour walk outpatient department , nearterm travel plan , etc.. ) Consent parent guardian least 18 year age . Signs critical illness define WHO ( WHO ( 2000 ) Severe falciparum malaria ; Clinical feature severe falciparum malaria child . Royal Society Tropical Medicine Hygiene , 94 ( supplement 1 ) , 511 ) . Signs severe complicate malaria define WHO ( WHO ( 2000 ) Severe falciparum malaria ; Clinical feature severe falciparum malaria child . Royal Society Tropical Medicine Hygiene , 94 ( supplement 1 ) , 511 ) . Severe anaemia ( haemoglobin &lt; 5 g/dL ) Known history hypersensitivity study medication , Symmetric oedema foot , Concomitant febrile illness originate malaria , could alter outcome study ( measles , acute low respiratory tract infection , otitis medium , tonsillitis , abscess , severe diarrhea dehydration , etc . ) , History full treatment course study drug past 28 day .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Artesunate-amodiaquine</keyword>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>Malnutrition</keyword>
</DOC>